These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 16147989)

  • 21. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
    Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
    Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive identification of exonic splicing enhancers in human genes.
    Fairbrother WG; Yeh RF; Sharp PA; Burge CB
    Science; 2002 Aug; 297(5583):1007-13. PubMed ID: 12114529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
    Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR
    Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why Selection Might Be Stronger When Populations Are Small: Intron Size and Density Predict within and between-Species Usage of Exonic Splice Associated cis-Motifs.
    Wu X; Hurst LD
    Mol Biol Evol; 2015 Jul; 32(7):1847-61. PubMed ID: 25771198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.
    Smith PJ; Zhang C; Wang J; Chew SL; Zhang MQ; Krainer AR
    Hum Mol Genet; 2006 Aug; 15(16):2490-508. PubMed ID: 16825284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition.
    Královicová J; Vorechovsky I
    Nucleic Acids Res; 2007; 35(19):6399-413. PubMed ID: 17881373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
    Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
    Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splicing of designer exons informs a biophysical model for exon definition.
    Arias MA; Lubkin A; Chasin LA
    RNA; 2015 Feb; 21(2):213-29. PubMed ID: 25492963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides.
    Aartsma-Rus A; Janson AA; Heemskerk JA; De Winter CL; Van Ommen GJ; Van Deutekom JC
    Ann N Y Acad Sci; 2006 Oct; 1082():74-6. PubMed ID: 17145928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The SRm160/300 splicing coactivator is required for exon-enhancer function.
    Eldridge AG; Li Y; Sharp PA; Blencowe BJ
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6125-30. PubMed ID: 10339552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
    Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
    Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human transformer 2beta and SRp55 interact with a calcitonin-specific splice enhancer.
    Tran Q; Coleman TP; Roesser JR
    Biochim Biophys Acta; 2003 Jan; 1625(2):141-52. PubMed ID: 12531473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A computational survey of candidate exonic splicing enhancer motifs in the model plant Arabidopsis thaliana.
    Pertea M; Mount SM; Salzberg SL
    BMC Bioinformatics; 2007 May; 8():159. PubMed ID: 17517127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF.
    Chen Z; Ma X; Zhang J; Hu J; Gorczynski RM
    Nucleic Acids Res; 2010 Oct; 38(19):6684-96. PubMed ID: 20558599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
    Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
    Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences.
    Schaal TD; Maniatis T
    Mol Cell Biol; 1999 Mar; 19(3):1705-19. PubMed ID: 10022858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse.
    Buvoli M; Buvoli A; Leinwand LA
    PLoS One; 2007 May; 2(5):e427. PubMed ID: 17487273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.